Swiss Soliris® and Ultomiris® Reimbursement Registry SSURR: An observational registry for capturing data of patients suffering from paroxysmal nocturnal hemoglobinuria (PNH) who are treated with Soliris® (eculizumab) or Ultomiris® (ravulizumab)

22/09/2020
27/03/2024
EU PAS number:
EUPAS37218
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information